COBRA: TOL+ INTERFERON-alpha COMBINED WITH VEMURAFENIB (BRAF-mutation positive patients) OR TOL + INTERFERON- alpha (BRAF-mutation negative patients) FOR PATIENTS WITH ADVANCED MELANOMA AS 1st CHEMOTHERAPY-BASED TREATMENT - COBRA

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2013
This article has no abstract
Epistemonikos ID: ee973c1692f454c51466571b351c1ebcbd98e039
First added on: Apr 17, 2025